Volume 2, ISSUE 2, 2021 (July - December)

Contents

Full issue

Editorial

What ́s in this issue

Juan Carlos Restrepo-Gutiérrez

293-294

Review articles

Renal dysfunction in the cirrhotic patient

Natalia Torres-Vellojín, Juan Camilo Díaz-Duque,
Jorge Luis Toro-Molina, Octavio G. Muñoz-Maya

295-309

Relevant aspects of nonalcoholic fatty liver disease

Isabel C. Hernández-Osorio, Marco Antonio Luján-Ramos

310-324

Primary sclerosing cholangitis

Amilkar José Almanza-Hurtado, Tomás Rodríguez-Yánez, María Cristina Martínez-Ávila, Jesús Daniel Rodríguez-Blanco, Pedro Luis Imbeth-Acosta

325-340

Portal vein thrombosis in liver cirrhosis

Jorge Luis Toro-Molina

Original article

Autoimmune liver diseases. Clinical and laboratory findings in patients in a national reference hospital

Julián David Martínez-Marín, Sandra Consuelo Henao-Riveros, Martín Alonso Garzón-Olarte

341-354

355-371

Case reports

Ascites in a patient with ulcerative colitis presenting Budd-Chiari syndrome: case report and literature review

Laura V. Galindo-Rozo, Daniela Cáceres-Escobar, Yanette Suárez-Quintero, Rómulo D. Vargas-Rubio, Alan F. Ovalle-Hernández

372-379

Non-cirrhotic portal hypertension: presentation
of four cases and a brief review of the literature

Christian Melgar-Burbano, Silvana Jiménez-Salazar, Kenny Buitrago-Toro, Linda Melgar-Burbano

380-391

“Non-classical” or “atypical” variant of Stauffer syndrome in a patient with clear cell renal carcinoma: a case report

Yalinne Gómez-Quesada, Rómulo D. Vargas-Rubio, Yanette Suárez-Quintero, Alan F. Ovalle-Hernández

392-397

392-397

Posters, XI International Congress of Hepatology

VOLUME 3, ISSUE 2, 2022 (JULY – DECEMBER)

Contents

Full issue

Editorial

Hepatobiliary disease in the COVID-19 era

Juan Carlos Restrepo-Gutiérrez

129-130

Review articles

Cardiomyopathy in patients with liver cirrhosis: review article

Esteban González-Domínguez, Diego Córdova, Paula Abad, Eduardo González, Camila González, Juan José Cordero

131-142

Hepatobiliary disease associated with COVID-19

Juan Carlos Restrepo-Gutiérrez, Ana Isabel Toro-Montoya

143-154

Conventional and emerging therapies in primary biliary cholangitis

Juan Camilo Díaz-Duque, Valeria Palacio-Valencia, Julissa Suárez-Meneses, Jesús Antonio Montaña-López, Eliana Palacio-Sánchez

155-175

Hyperbilirubinemia: pathologist's view

Germán Osorio-Sandoval, Nancy Johana Mejía-Vargas, Juan Camilo Pérez-Cadavid, Alejandro Cardona-Palacio

176-190

Original articles

Histological liver changes caused by chronic intake of monosodium glutamate

Ana Patricia Fabro, María del Carmen Contini, Noelia Villafañe, Adriana Benmelej

191-202

Primary biliary cholangitis: characterization of a retrospective cohort

Edgar Fernando Ayala-Sierra, Octavio G. Muñoz-Maya, Felipe Guerrero-Pérez, Manuela Cardona-Jaramillo

203-217

Case reports

Hepatic hydrothorax as a rare complication of cirrhosis. A therapeutic challenge in advanced cirrhosis

Melissa Lara-Viáfara, Mauricio Salazar-Moreno, Juliana Suárez-Correa, Oscar Reyna-Carrasco

218-224

Sclerosing cholangitis associated with severe infection by SARS-CoV-2

Natalia Torres-Vellojín, Juan Camilo Díaz-Duque, Luz Adriana Gómez-Ramírez, Octavio G. Muñoz-Maya

225-232